BIOGEN for BIOGEN
A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 2nd Quarter - Report (this page) | Jul 18, 2008 | $220,000 | Replaced |
| 2nd Quarter - Report | Oct 16, 2008 | $180,000 | Yes |
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Follow on Biologics, including S 1695, HR 1956, HR 1038, and HR 5629. Generating support for Committee/House consideration.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ADAM GLUCK | Staff, Senate Appropriations Committee |
| KATHLEEN TREGONING | Staff, Senate Budget Committee |
Copyright/Patent/Trademark CPT
Patent Reform -- S. 1145 and HR 1908 provisions related to apportionment of damages, inequitable conduct, and post-grant/second window.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ADAM GLUCK | Staff, Senate Appropriations Committee |
| KATHLEEN TREGONING | Staff, Senate Budget Committee |
Medicare/Medicaid MMM
1) Comparative effectiveness provisions -- supporting increased transparency/reporting requirements. 2) Physician gift disclosure provisions
| Lobbyist | Covered position, as disclosed |
|---|---|
| ADAM GLUCK | Staff, Senate Appropriations Committee |
| KATHLEEN TREGONING | Staff, Senate Budget Committee |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.